Cyteir Therapeutics, Inc.
CYTDelisted Mar 18, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001662244
Cyteir Therapeutics, Inc. was delisted on Mar 18, 2024; its insiders filed their last Form 4 on Mar 25, 2024; 38 institutions reported holding it in 13F filings for Q4 2023, worth $38.9M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Cyteir Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- −8 vs. Q2 2022
- Shares held
- 18.0M
- −1.03M (−5.4%) vs. Q2 2022
- Total value
- $34.6M
- −$22.2M (−39.1%) vs. Q2 2022
- New holders
- 2
- 11 more added
- Sold out
- 10
- 14 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CYT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 4 | $11.2M |
| Q4 2023 | 38 | $38.9M |
| Q3 2023 | 41 | $46.3M |
| Q2 2023 | 39 | $41.7M |
| Q1 2023 | 32 | $23.9M |
| Q4 2022 | 30 | $28.5M |
| Q3 2022 | 37 | $34.6M |
| Q2 2022 | 45 | $56.8M |
| Q1 2022 | 52 | $83.8M |
| Q4 2021 | 48 | $253.4M |
| Q3 2021 | 38 | $344.1M |
| Q2 2021 | 33 | $352.6M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Cyteir Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 94 | $0 | 0.00% | +44+88.0% | Added |
| Daiwa Securities Group Inc. | 103 | $0 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 669 | $1.00K | 0.00% | −266−28.4% | Reduced |
| Parallel Advisors, LLC | 464 | $1.00K | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 332 | $1.00K | 0.00% | +332 | New |
| Steward Partners Investment Advisory, LLC | 2,200 | $4.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2,032 | $4.00K | 0.00% | +614+43.3% | Added |
| Lindbrook Capital, LLC | 2,006 | $4.00K | 0.00% | +2,000+33,333.3% | Added |
| Tower Research Capital LLC (TRC) | 5,859 | $11.0K | 0.00% | −141−2.4% | Reduced |
| Goldman Sachs Group Inc | 11,670 | $22.0K | 0.00% | −12,769−52.2% | Reduced |
| Qube Research & Technologies Ltd | 11,796 | $23.0K | 0.00% | +522+4.6% | Added |
| Mariner, LLC | 11,852 | $23.0K | 0.00% | +11,852 | New |
| Two Sigma Investments, LP | 13,093 | $25.0K | 0.00% | −11,269−46.3% | Reduced |
| Northern Trust Corp | 13,175 | $25.0K | 0.00% | 00.0% | Unchanged |
| ACT Capital Management, LLC | 15,000 | $29.0K | 0.04% | 00.0% | Unchanged |
| Cannell Capital LLC | 19,684 | $38.0K | 0.01% | +15,793+405.9% | Added |
| Bank of America Corp | 21,007 | $40.0K | 0.00% | −5,361−20.3% | Reduced |
| State Street Corp | 23,853 | $46.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 28,300 | $54.0K | 0.00% | +5,900+26.3% | Added |
| UBS Group AG | 34,809 | $67.0K | 0.00% | +5,473+18.7% | Added |
| Morgan Stanley | 69,334 | $133.0K | 0.00% | −146,039−67.8% | Reduced |
| Geode Capital Management, LLC | 113,628 | $218.0K | 0.00% | +36,041+46.5% | Added |
| Millennium Management LLC | 119,234 | $229.0K | 0.00% | −7,915−6.2% | Reduced |
| Bridgeway Capital Management, LLC | 119,584 | $230.0K | 0.01% | +50,000+71.9% | Added |
| Evercore Wealth Management, LLC | 146,676 | $282.0K | 0.01% | 00.0% | Unchanged |
| RBF Capital, LLC | 152,382 | $293.0K | 0.03% | 00.0% | Unchanged |
| BlackRock Inc. | 196,912 | $376.0K | 0.00% | −4,592−2.3% | Reduced |
| Renaissance Technologies LLC | 266,821 | $512.0K | 0.00% | −80,521−23.2% | Reduced |
| Laurion Capital Management LP | 359,500 | $690.0K | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 584,492 | $1.12M | 0.00% | −27,106−4.4% | Reduced |
| Newtyn Management, LLC | 654,112 | $1.26M | 0.28% | +47,864+7.9% | Added |
| Caas Capital Management LP | 616,822 | $1.27M | 0.17% | +536,938+672.1% | Added |
| Avidity Partners Management LP | 1,806,200 | $3.47M | 0.08% | −43,800−2.4% | Reduced |
| OUP Management Co., LLC | 2,469,572 | $4.74M | 7.38% | −5,000−0.2% | Reduced |
| Baker Bros. Advisors LP | 2,643,640 | $5.08M | 0.03% | 00.0% | Unchanged |
| FMR LLC | 3,486,058 | $6.69M | 0.00% | −386,231−10.0% | Reduced |
| Novo Holdings A/S | 3,940,413 | $7.57M | 0.36% | −900,000−18.6% | Reduced |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −58,529−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −17,557−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −13,900−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −11,282−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −10,278−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −189−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −49−100.0% | Sold out |